SCHEMBL14796002

SCHEMBL14796002

CN(C)c1ccc2[nH]c(=O)c(-c3nc4ccccc4[nH]3)c(N[C@@H]3CN4CCC3CC4)c2c1

nearest known ligand 0.80

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 16/20 0.80
PRKD3 O94806 3/20 0.67
PRKCG P05129 3/20 0.67
PRKCB P05771 3/20 0.67
PRKCA P17252 3/20 0.67
CCNA2 P20248 3/20 0.67
PRKCH P24723 3/20 0.67
CDK2 P24941 3/20 0.67
PRKCI P41743 3/20 0.67
PRKCE Q02156 3/20 0.67
PRKCQ Q04759 3/20 0.67
PRKCZ Q05513 3/20 0.67
PRKCD Q05655 3/20 0.67
PRKD1 Q15139 3/20 0.67
AURKA O14965 1/20 0.52
PDGFRB P09619 4/20 0.51
FGFR1 P11362 4/20 0.51
KDR P35968 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15910767 0.94 CHEK1 (0.75) CHEK1PRKD3PRKCGPRKCBPRKCA
SCHEMBL15910750 0.93 CHEK1 (0.79) CHEK1PRKD3PRKCGPRKCBPRKCA
SCHEMBL6387344 0.89 CHEK1 (1.00) CHEK1PRKD3PRKCGPRKCBPRKCA
SCHEMBL3381001 0.89 CHEK1 (1.00) CHEK1PRKD3PRKCGPRKCBPRKCA
SCHEMBL3381730 0.89 CHEK1 (1.00) CHEK1PRKD3PRKCGPRKCBPRKCA
SCHEMBL3381807 0.89 CHEK1 (1.00) CHEK1PRKD3PRKCGPRKCBPRKCA
SCHEMBL3382255 0.89 CHEK1 (1.00) CHEK1PRKD3PRKCGPRKCBPRKCA
SCHEMBL3379993 0.87 CHEK1 (0.83) CHEK1PRKD3PRKCGPRKCBPRKCA
SCHEMBL3384695 0.87 CHEK1 (1.00) CHEK1PRKD3PRKCGPRKCBPRKCA
SCHEMBL3383642 0.87 CHEK1 (0.83) CHEK1PRKD3PRKCGPRKCBPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2762475-A1 Pharmaceutically acceptable salts of quinolinone compounds and their medical use Novartis Vaccines and Diagnostics, Inc. (US) 2014-08-06 EP disclosed
EP-2573079-A2 Benzimidazole quinolinones and uses thereof Novartis Vaccines and Diagnostics, Inc. (US) 2013-03-27 EP disclosed